MedTrace Logo

Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants

NCT05987475 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2023-11-29

No results posted yet for this study

Summary

Prospective observational clinical follow-up of Euromi Biosciences silicone gel-filled breast implants - Post-market clinical investigation - ELEGANT

Conditions

  • Breast Implant Rupture
  • Breast Implant; Complications

Interventions

PROCEDURE

Breast reconstruction

Breast reconstruction and breast augmentation based on the indications as listed out in the instructions for use of the medical device under investigation

Sponsors & Collaborators

  • Euromi Biosciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-18
Primary Completion
2034-09-30
Completion
2034-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05987475 on ClinicalTrials.gov